These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 409025)

  • 1. Classic hemophilia A in a female.
    Joist JH; Bouhasin JD; Roodman S
    Acta Haematol; 1977; 58(2):94-102. PubMed ID: 409025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
    Guimbretére J
    Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence.
    Miller CH; Hilgartner MW; Harris MB; Bussel JB; Aledort LM
    Am J Med Genet; 1986 May; 24(1):83-94. PubMed ID: 3085499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of von Willebrand's disease].
    Baklaja R; Stojimirović E; Kezić J; Cuperlović K; Jovanović B; Cvetković V; Rasović N; Stajić M
    Bilt Hematol Transfuz; 1977; 5(3-4):41-61. PubMed ID: 307953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic problems of von Willebrand's disease in a general hospital laboratory.
    Dahl CJ; McRoyan DK; Liu PI
    Ann Clin Lab Sci; 1983; 13(5):371-8. PubMed ID: 6416137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in hematology. Willebrand's disease and hemophilia A in the light of latest studies of the factor VIII].
    Zawilska K
    Pol Arch Med Wewn; 1976 Aug; 56(8):179-84. PubMed ID: 787944
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.
    Stites DP; Hershgold EJ; Perlman JD; Fudenberg HH
    Science; 1971 Jan; 171(3967):196-7. PubMed ID: 5312959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the carrier state for classic hemophilia using an enzyme-linked immunosorbent assay (ELISA).
    Fishman DJ; Jones PK; Menitove JE; Ratnoff OD; Everson B
    Blood; 1982 Jun; 59(6):1163-8. PubMed ID: 6805530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of von Willebrand's disease.
    Triplett DA
    Mayo Clin Proc; 1991 Aug; 66(8):832-40. PubMed ID: 1907342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.